Drawing for ISOLOGIC

USPTO serial 99536121

ISOLOGIC

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
STEPHENS, BRIA MICHELLE
Law office
TMO LAW OFFICE 122

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with ISOLOGIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Katherine P. Califa

Katherine P. Califa Foley & Lardner LLP3000 K Street, N.W.Sixth FloorWashington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005Radiopharmaceutical and radioisotope preparations for clinical, medical, medical diagnostic and therapeutic useACTIVE—
035Distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations; Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodiesACTIVE—
039Supply chain and logistics services, namely, transportation, delivery, distribution in the nature of delivery, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services being the transport and storage of radiopharmaceuticals and radioisotopesACTIVE—
040Isotope production being the manufacture of isotopes for products being sold to others for medical, research, and commercial use; contract manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials; Manufacturing services for others in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticalsACTIVE—
042Laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services in the field of radiopharmaceutical manufacturing, namely developing and scaling manufacturing processes for radiopharmaceuticals, pharmaceuticals, and nuclear medicine products for others; technological consultancy relating to radiopharmaceutical production and regulatory compliance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others; Scientific and technological services namely, research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine; contract manufacturing services in the field of pharmaceuticals and radiopharmaceuticalsACTIVE—
044radiopharmacy services, namely, preparation and dispensing of radiopharmaceuticals for diagnostic and therapeutic purposes; consultation and clinical support services related to the preparation and administration of radiopharmaceuticals and radioisotopesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 25, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 25, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 10, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2026DOCKASSIGNED TO EXAMINER—
Feb 13, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 8, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 8, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance